Learn More
Medchemexpress LLC Abeprazan hydrochloride | 1902954-87-3 | 99.9% | 446.87 | 50 MG

Supplier: Medchemexpress LLC HY109079A10MM/1ML
Abeprazan hydrochloride (DWP14012 hydrochloride) is a potassium-competitive acid blocker that inhibits H+, K+- ATPase through reversible potassium-competitive ionic binding without requiring acid activation. It is being developed as a potential alternative to proton pump inhibitors for treating acid-related diseases.
- Potassium-competitive acid blocker.
- Inhibits H+, K+- ATPase by reversible potassium-competitive ionic binding.
- Does not require acid activation for its inhibitory mechanism.
- Developed as a potential alternative for proton pump inhibitors.
- Inhibits acid secretion in a dose-dependent manner in in vivo studies.
- Efficacy is equal to or greater than that of vonoprazan in various in vivo studies.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.